Hypoxic vasoconstriction in intact lungs: a role for NADPH oxidase-derived H(2)O(2)?
Hypoxic pulmonary vasoconstriction (HPV) matches lung perfusion with ventilation. Controversy exists whether decreased or increased reactive oxygen species may elicit HPV and from which source such oxygen metabolites are derived. In rabbit lungs, we detected transcripts of a nonphagocytic NADPH oxidase subunit homologous to mitogenic oxidase-1 (Mox1) or NADPH oxidase homolog 1 (NOH-1L). In perfused rabbit lungs, we employed 1) a new NADPH oxidase inhibitor [4-(2-aminoethyl)benzenesulfonyl fluoride (AEBSF; 100-600 microM)] and 2) the superoxide dismutase (SOD) inhibitors diethyldithiocarbamic acid (DETC; 100 microM to 10 mM) and triethylenetetramine (TETA; 1-25 mM). Specificity of these agents for HPV was investigated by comparison with U-46619-induced vasoconstrictions. AEBSF induced a transient increase in pulmonary arterial pressure with increased strength of HPV. Subsequent to this initial response, normoxic pulmonary arterial pressure was not affected and HPV was specifically suppressed. Whereas DETC turned out to act in a nonspecific fashion, TETA suppressed HPV specifically. These findings provide evidence of a role for a nonphagocytic NAD(P)H oxidase with superoxide and SOD-related hydrogen peroxide formation in HPV. Because HPV was inhibited but not mimicked by the inhibitors, increased rather than decreased superoxide and/or hydrogen peroxide formation is suggested as the hypoxia-provoked signaling event.
Weissmann
N
N
Department of Internal Medicine, Justus-Liebig-University Giessen, 35392 Giessen, Germany. Norbert.Weissmann@innere.med.uni-giessen.de
Tadic
A
A
Hänze
J
J
Rose
F
F
Winterhalder
S
S
Nollen
M
M
Schermuly
R T
RT
Ghofrani
H A
HA
Seeger
W
W
Grimminger
F
F
D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D004050:Ditiocarb / Q000494:pharmacology; D005260:Female; D006861:Hydrogen Peroxide / Q000378:metabolism*; D000860:Hypoxia / Q000503:physiopathology*; D066298:In Vitro Techniques; D008168:Lung / Q000098:blood supply / Q000502:physiology* / Q000503:physiopathology; D008297:Male; D019255:NADPH Oxidases / Q000235:genetics / Q000378:metabolism*; D011652:Pulmonary Circulation / Q000187:drug effects / Q000502:physiology*; D011817:Rabbits; D017382:Reactive Oxygen Species / Q000502:physiology; D013450:Sulfones / Q000494:pharmacology; D014158:Transcription, Genetic; D014266:Trientine / Q000494:pharmacology; D014661:Vasoconstriction / Q000187:drug effects / Q000502:physiology*
D017382:Reactive Oxygen Species; D013450:Sulfones; C002010:4-(2-aminoethyl)benzenesulfonylfluoride; D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D004050:Ditiocarb; D006861:Hydrogen Peroxide; D019255:NADPH Oxidases; D014266:Trientine